MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy

Expert Opinion on Medical Diagnostics

Volumn 7, Issue 4, 2013, Pages 393-403

  Berkowitz, Bruce A ^a,b   Bissig, David ^a   Dutczak, Oliver ^a   Corbett, Shannon ^a   North, Rob ^a   Roberts, Robin ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Animal models; Calcium channels; Diabetes; MRI; Retinopathy

Indexed keywords

11 CIS RETINAL; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BAYK 8644; BIOLOGICAL MARKER; CAPTOPRIL; DILTIAZEM; ENALAPRIL; LIGAND GATED ION CHANNEL; LOSARTAN; MANGANESE CHLORIDE; NIFEDIPINE; RHODOPSIN; THIOCTIC ACID; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VASODILATOR AGENT; VERAPAMIL;

ANTIOXIDANT ACTIVITY; AUTOREGULATION; DARK ADAPTATION; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG UPTAKE; HUMAN; LIGHT ADAPTATION; MEMBRANE DEPOLARIZATION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; REPERFUSION INJURY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA DEGENERATION; RETINA NEOVASCULARIZATION; REVIEW; TREATMENT DURATION; ANIMAL; DISEASE MODEL; PROCEDURES;

ANIMALS; BIOLOGICAL MARKERS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84879646550     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2013.814639     Document Type: Review

References (93)

1. Kiss B, Polska E, Dorner G, et al. Retinal blood flow during hyperoxia in humans revisited: Concerted results using different measurement techniques. Microvasc Res 2002 ;64:75-85 (Pubitemid 34713233)
2. Higashi S, Clermont AC, Dhir V, Bursell SE. Reversibility of retinal flow abnormalities is disease-Duration dependent in diabetic rats. Diabetes 1998 ;47:653-9 (Pubitemid 28160458)
3. Konno S, Feke GT, Yoshida A, et al. Retinal blood flow changes in type I diabetes -A long-Term, follow-up study. Invest Ophthalmol Vis Sci 1996 ;37:1140-8
4. Bursell SE, Clermont AC, Oren B, King GL. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci 1995 ;36:596-607
5. Kern TS, Tang J, Berkowitz BA. Validation of structural and functional lesions of diabetic retinopathy in mice. Mol Vis 2010 ;16:2121-3
6. Guan K, Hudson C, Wong T, et al. Retinal hemodynamics in early diabetic macular edema. Diabetes 2006 ;55:813-18 (Pubitemid 43343241)
7. Lorenzi M, Feke GT, Pitler L, et al. Defective myogenic response to posture change in retinal vessels of well-controlled type 1 diabetic patients with no retinopathy. Invest Ophthalmol Vis Sci 2010 ;51:6770-5
8. Lorenzi M, Feke GT, Cagliero E, et al. Retinal haemodynamics in individuals with well-controlled type 1 diabetes. Diabetologia 2008 ;51:361-4
9. Berkowitz BA, Roberts R. Prognostic MRI biomarkers of treatment efficacy for retinopathy. NMR Biomed 2008 ;21:957-67
10. Trick GL, Burde RM, Gordon MO, et al. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology 1988 ;95:693-8
11. Jackson G, Barber A. Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep 2010 ;10:380-4
12. Tang J, Mohr S, Du YD, Kern TS. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr Eye Res 2003 ;27:7-13 (Pubitemid 36936342)
13. Adams AJ, Bearse MA Jr. Retinal neuropathy precedes vasculopathy in diabetes: A function-based opportunity for early treatment intervention? Clin Exp Optom 2012 ;95:256-6
14. Ball SL, Petry HM. Noninvasive assessment of retinal function in rats using multifocal electroretinography. Invest Ophthalmol Vis Sci 2000 ;41:610-17 (Pubitemid 30080468)
15. Nusinowitz S, Ridder WH, Heckenlively Jr. Rod multifocal electroretinograms in mice. Invest Ophthalmol Vis Sci 1999 ;40:2848-58 (Pubitemid 29521598)
16. Cogan DG, Kuwabara T. Comparison of retinal and cerebral vasculature in trypsin digest preparations. Br J Ophthalmol 1984 ;68:10-12 (Pubitemid 15134733)
17. Shih YY, Muir ER, Li G, et al. High-resolution 3D MR microangiography of the rat ocular circulation. Radiology 2012 ;264:234-41
18. Berkowitz BA, Bissig D, Patel P, et al. Acute systemic 11-cis-retinal intervention improves abnormal outer retinal ion channel closure in diabetic mice. Mol Vis 2012 ;18:372-6
19. Li X, McClellan ME, Tanito M, et al. Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem 2012 ;287:16424-34
20. Berkowitz BA, Gradianu M, Bissig D, et al. Retinal ion regulation in a mouse model of diabetic retinopathy: Natural history and the effect of Cu/Zn superoxide dismutase overexpression. Invest Ophthalmol Vis Sci 2009 ;50:2351-
21. Berkowitz BA, Roberts R, Luan H, et al. Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury. Invest Ophthalmol Vis Sci 2007 ;48:3796-804 (Pubitemid 351261120)
22. Berkowitz BA, Roberts R, Stemmler A, et al. Impaired apparent ion demand in experimental diabetic retinopathy: Correction by lipoic acid. Invest Ophthalmol Vis Sci 2007 ;48:4753-8 (Pubitemid 351260995)
23. Berkowitz BA, Roberts R, Goebel DJ, Luan H. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci 2006 ;47:2668-74 (Pubitemid 351639856)
24. Ames A III, Li YY, Heher EC, Kimble CR. Energy metabolism of rabbit retina as related to function: High cost of Na+ transport. J Neurosci 1992 ;12:840-53
25. Linton JD, Holzhausen LC, Babai N, et al. Flow of energy in the outer retina in darkness and in light. PNAS 2010 ;107:8599-604
26. Tofts PS, Porchia A, Jin Y, et al. Toward clinical application of manganese-enhanced MRI of retinal function. Brain Res Bull 2010 ;81:333-8
27. Berkowitz BA, Roberts R, Luan H, et al. Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury. Invest Ophthalmol Vis Sci 2007 ;48:3796-804 (Pubitemid 351261120)
28. Berkowitz BA, Roberts R, Penn JS, Gradianu M. High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2007 ;48:4733-40 (Pubitemid 351260992)
29. Bissig D, Berkowitz BA. Same-session functional assessment of rat retina and brain with manganese-enhanced MRI. Neuroimage 2011 ;58:749-60
30. Au C, Benedetto A, Aschner M. Manganese transport in eukaryotes: The role of DMT1. Neurotoxicology 2008 ;29:569-76
31. Wang CY, Jenkitkasemwong S, Duarte S, et al. ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J Biol Chem 2012 ;287:34032-43
32. Schmitz Y, Witkovsky P. Dependence of photoreceptor glutamate release on a dihydropyridine-sensitive calcium channel. Neuroscience 1997 ;78:1209-16 (Pubitemid 27223723)
33. Nachman-Clewner M, Jules R, Townes-Anderson E. L-Type calcium channels in the photoreceptor ribbon synapse: Localization and role in plasticity. J Comp Neurol 1999 ;415:1-16 (Pubitemid 29519882)
34. Avendano G, Butler BJ, Michael Iuvone P. K+-evoked depolarization induces serotonin N-Acetyltransferase activity in photoreceptor-enriched retinal cell cultures. Involvement of calcium influx through l-Type channels. Neurochem Int 1990 ;17:117-26 (Pubitemid 20224185)
35. Drapeau P, Nachshen DA. Manganese fluxes and manganese-Dependent neurotransmitter release in presynaptic nerve endings isolated from rat brain. J Physiol 1984 ;348:493-510 (Pubitemid 14061866)
36. Carlson RO, Masco D, Brooker G, Spiegel S. Endogenous ganglioside GM1 modulates L-Type calcium channel activity in N18 neuroblastoma cells. J Neurosci 1994 ;14:2272-81 (Pubitemid 24108132)
37. Cross DJ, Flexman JA, Anzai Y, et al. In vivo manganese MR imaging of calcium influx in spontaneous rat pituitary adenoma. AJNR Am J Neuroradiol 2007 ;28:1865-71 (Pubitemid 350174724)
38. Berkowitz BA, Bissig D, Bergman D, et al. Intraretinal calcium channels and retinal morbidity in experimental retinopathy of prematurity. Mol Vis 2011 ;17:2516-26
39. Pritschow B, Lange T, Kasch J, et al. Functional TRPV4 channels are expressed in mouse skeletal muscle and can modulate resting Ca2+ influx and muscle fatigue. Pflugers Arch Eur J Physiol 2011 ;461:115-22
40. Itoh K, Sakata M, Watanabe M, et al. The entry of manganese ions into the brain is accelerated by the activation of N-methyl-D-Aspartate receptors. Neuroscience 2008 ;154:732-40
41. Berkowitz BA, Roberts R, Oleske DA, et al. Quantitative mapping of ion channel regulation by visual cycle activity in rodent photoreceptors in vivo. Invest Ophthalmol Vis Sci 2009 ;1880-5
42. Berkowitz BA, Roberts R, Bissig D. Light-Dependant intraretinal ion regulation by melanopsin in young awake and free moving mice evaluated with manganese-enhanced MRI. Mol Vis 2010 ;16:1776-80
43. Ivanova E, Roberts R, Bissig D, et al. Retinal channelrhodopsin-2- mediated activity in vivo evaluated with manganese-enhanced magnetic resonance imaging. Mol Vis 2010 ;16:1059-67
44. Crosson CE, Willis JA, Potter DE. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol 1990 ;6:293-9
45. Toriu N, Akaike A, Yasuyoshi H, et al. Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res 2000 ;70:475-84 (Pubitemid 30658889)
46. Hirooka K, Kelly MEM, Baldridge WH, Barnes S. Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuroprotective effects. Exp Eye Res 2000 ;70:611-21
47. Massote P, Pinheiro A, Fonseca C, et al. Protective Effect of retinal ischemia by blockers of voltage-Dependent calcium channels and intracellular calcium stores. Cell Mol Neurobiol 2008 ;28:847-56
48. Berkowitz BA, Gradianu M, Schafer S, et al. Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI. Invest Ophthalmol Vis Sci 2008 ;49:3178-84
49. Zheng L, Gong B, Hatala DA, Kern TS. Retinal Ischemia and reperfusion causes capillary degeneration: Similarities to diabetes. Invest Ophthalmol Vis Sci 2007 ;48:361-7 (Pubitemid 47251425)
50. Zhu Y, Zhang Y, Ojwang BA, et al. Long-Term tolerance to retinal ischemia by repetitive hypoxic preconditioning: Role of HIF-1alpha and heme oxygenase-1. Invest Ophthalmol Vis Sci 2007 ;48:1735-43 (Pubitemid 351261360)
51. Anthuber M, Farkas S, Rihl M, et al. Angiotensin-converting enzyme inhibition by enalapril: A novel approach to reduce ischemia/reperfusion damage after experimental liver transplantation. Hepatology 1997 ;25:648-51 (Pubitemid 27106448)
52. Fischer S, MacLean AA, Liu M, et al. Inhibition of angiotensin-converting enzyme by captopril: A novel approach to reduce ischemia-reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 2000 ;120:573-80
53. Flynn JD, Akers WS. Effects of the Angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion. Pharmacotherapy 2003 ;23:1401-10 (Pubitemid 37315031)
54. Messadi-Laribi E, Griol-Charhbili V, Gaies E, et al. Cardioprotection and kallikreingçôkinin system in acute myocardial ischaemia in mice. Clin Exp Pharmacol Physiol 2008 ;35:489-93 (Pubitemid 351326785)
55. Køber L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-convertingg-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995 ;333:1670-6 (Pubitemid 26001955)
56. Morris SD, Yellon DM. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. J Am Coll Cardiol 1997 ;29:1599-606 (Pubitemid 27272456)
57. Leesar MA, Jneid H, Tang XL, Bolli R. Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. J Am Coll Cardiol 2007 ;49:1607-10 (Pubitemid 46551636)
58. Alvin Z, Laurence GG, Coleman BR, et al. Regulation of L-Type inward calcium channel activity by captopril and angiotensin II via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts. Can J Physiol Pharmacol 2011 ;89:206-15
59. Bryant SM, Ryder KO, Hart G. Effects of captopril on membrane current and contraction in single ventricular myocytes from guinea-pig. Br J Pharmacol 1991 ;102:462-6
60. Wang J, Zhang L, Qi JH, et al. Effects of captopril and enalaprilat on intracellular Ca2+ content in isolated cardiomyocytes from rats. Zhongguo Yao Li Xue Bao 1996 ;17:233-5
61. Bartosz M, Kedziora J, Bartosz G. Antioxidant and prooxidant properties of captopril and enalapril. Free Radic Biol Med 1997 ;23:729-35 (Pubitemid 27364866)
62. de Cavanagh EM, Fraga CG, Ferder L, Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol 1997 ;272:R514-18
63. Scribner AW, Loscalzo J, Napoli C. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol 2003 ;482:95-9 (Pubitemid 37505931)
64. Sugimoto KI, Tsuruoka S, Fujimura A. Effect of enalapril on diabetic nephropathy in oletf rats: The role of an anti-oxidative action in its protective properties. Clin Exp Pharmacol Physiol 2001 ;28:826-30 (Pubitemid 32947179)
65. Kedziora-Kornatowska K. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats. Clin Chim Acta 1999 ;287:19-27 (Pubitemid 29413006)
66. Yamasaki T, Kawahara M, Akiyama Y, et al. Effect of enalaprilat, an angiotensin converting enzyme inhibitor, on the membrane potential of cultured neuroblastoma-glioma hybrid NG108-15 cells. No To Shinkei 1993 ;45:1039-44 (Pubitemid 24013970)
67. De Mello WC, Cherry RC, Manivannan S. Electrophysiologic and morphologic abnormalities in the failing heart: Effect of enalapril on the electrical properties. J Card Fail 1997 ;3:53-61 (Pubitemid 127675008)
68. De Mello WC. Electrical activity of the heart and angiotensin-converting enzyme inhibitors on the hyperpolarising action of enalapril. J Hum Hypertens 2002 ;16(Suppl 1):S89-92 (Pubitemid 34441143)
69. Fukuda K, Hirooka K, Mizote M, et al. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 2010 ;51:3629-38
70. Zhang JZ, Xi X, Gao L, Kern TS. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Curr Eye Res 2007 ;32:883-9 (Pubitemid 350034786)
71. Peng PH, Huang HS, Lee YJ, et al. Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas. J Neurochem 2009 ;108:741-54
72. Benzie IF, Tomlinson B. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br J Clin Pharmacol 1998 ;45:168-9 (Pubitemid 28045686)
73. De NF, D'Armiento FP, Somma P, et al. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. Int J Cardiol 2001 ;81:107-15 (Pubitemid 34017424)
74. Goldschmidt JE, Tallarida RJ. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: Effect of sulfhydryl groups on endothelium-Derived relaxing factor. J Pharmacol Exp Ther 1991 ;257:1136-45
75. de Cavanagh EMV, Inserra F, Toblli J, et al. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 2001 ;38:1130-6 (Pubitemid 34252818)
76. Agostinho P, Duarte CB, Carvalho AP, Oliveira CR. Oxidative stress affects the selective ion permeability of voltage-sensitive Ca2+ channels in cultured retinal cells. Neurosci Res 1997 ;27:323-34 (Pubitemid 27176581)
77. Shirotani K, Katsura M, Higo A, et al. Suppression of Ca2+ influx through L-Type voltage-Dependent calcium channels by hydroxyl radical in mouse cerebral cortical neurons. Brain Res Mol Brain Res 2001 ;92:12-18 (Pubitemid 32718700)
78. Pulukuri S, Sitaramayya A. Retinaldehyde, a potent inhibitor of gap junctional intercellular communication. Cell Commun Adhes 2004 ;11:25-33 (Pubitemid 39069728)
79. Long AC, Bomser JA, Grzybowski DM, Chandler HL. All-Trans retinoic acid regulates cx43 expression, gap junction communication and differentiation in primary lens epithelial cells. Curr Eye Res 2010 ;35:670-9
80. Zhang DQ, McMahon DG. Direct gating by retinoic acid of retinal electrical synapses. Proc Natl Acad Sci USA 2000 ;97:14754-9 (Pubitemid 32016647)
81. Bissig D, Goebel D, Berkowitz BA. Diminished vision in healthy aging is associated with increased retinal l-Type voltage gated calcium channel ion influx. PLoS ONE 2013;8:e56340
82. Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009 ;361:40-51
83. Salido EM, Dorfman D, Bordone M, et al. Ischemic conditioning protects the rat retina in an experimental model of early type 2 diabetes. Exp Neurol 2013 ;240:1-8
84. Fernandez DC, Sande PH, Chianelli MS, et al. Induction of ischemic tolerance protects the retina from diabetic retinopathy. Am J Pathol 2011 ;178:2264-74
85. Zheng Z, Chen H, Ke G, et al. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-To-pigment epithelium-Derived factor ratio: Involvement of a mitochondria-reactive oxygen species pathway. Diabetes 2009 ;58:954-64
86. Ebrahimian TG, Tamarat R, Clergue M, et al. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol 2005 ;25:65-70 (Pubitemid 40054255)
87. Zheng Z, Chen H, Xu X, et al. Effects of angiotensin-converting enzyme inhibitors and beta-Adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy. Exp Eye Res 2007 ;84:745-52 (Pubitemid 46400640)
88. Barnett J, Yanni S, Penn J. The development of the rat model of retinopathy of prematurity. Doc Ophthalmol 2010 ;120:3-12
89. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994 ;35:101-11 (Pubitemid 24046832)
90. Berkowitz BA, Penn JS. Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 1998 ;39:840-5 (Pubitemid 28207482)
91. Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci 1995 ;36:2063-70
92. Penn JS, Henry MM, Tolman BL. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res 1994 ;36:724-31 (Pubitemid 24357783)
93. Berkowitz BA, McDonald C, Ito Y, et al. Measuring the human retinal oxygenation response to a hyperoxic challenge using MRI: Eliminating blinking artifacts and demonstrating proof of concept. Magn Reson Med 2001 ;46:412-16 (Pubitemid 32703290)